Summary:
Household contacts living with a SARS-COV-2-infected individual are at elevated risk of developing COVID-19 due to their extended close proximity with this individual who is shedding virus. Although multiple vaccines are currently being distributed and a global effort is underway to vaccinate the population as rapidly as possible, emerging variants are appearing. Recent evidence has suggested that vaccine protection may be reduced, perhaps substantially, against this variant. This study medication may be an effective means to prevent illness after exposure to SARS CoV 2, including SARS-CoV-2 variants with spike gene mutations for which current vaccines may not provide protection.
Qualified Participants Must:
• 18 years of age or older
• do not have confirmed or suspected COVID-19
• are residing with an individual (of any age) with COVID-19 (laboratory-confirmed SARS-CoV-2 infection with symptoms
Qualified Participants May Receive:
Reimbursement for time and travel, $100 per completed visit